English

Intellicell Biosciences, Inc.

EDGAR

Filing amendment (SC 13G/A) · filed 2017-01-11

82 filing records in this dataset, filed from 2001-05-14 to 2017-01-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

55 thousand USD

2014 Q3 · USD

Exact inputs and evidence

Revenue: 55000 USD Source

Operating margin

-2,646.33%

2014 Q3 · %

Exact inputs and evidence

Operating Income: -1455484 USD Source
Revenue: 55000 USD Source

Operating cash flow

-560 thousand USD

2014 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -2731462 USD Source
Operating Cash Flow: -2171039 USD Source

Free cash flow

-597 thousand USD

2014 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -2731462 USD Source
Operating Cash Flow: -2171039 USD Source
Capital Expenditure: 67064 USD Source
Capital Expenditure: 30557 USD Source

Cash and cash equivalents: 48.1 thousand USD 2014-09-30 Source
Exact value

48080 USD
Long-term debt including current maturities: Not available
Shares outstanding: 3.72 billion shares 2014-09-30 Source
Exact value

3717753280 shares

Reported share-count change

2,888.45% · 3.59 billion shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

124404170 shares · 2013-09-30· Source
3717753280 shares · 2014-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

120 thousand USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Revenue: 0 USD · 2013-01-01 – 2013-12-31 Source
Revenue: 0 USD · 2013-01-01 – 2013-09-30 Source
Revenue: 32500 USD · 2014-01-01 – 2014-03-31 Source
Revenue: 32500 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 55000 USD · 2014-07-01 – 2014-09-30 Source

Operating cash flow

-3.45 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Operating cash flow: -1159641 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -440126 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -1522669 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -2171039 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -1522669 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -2731462 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -2171039 USD · 2014-01-01 – 2014-06-30 Source

Capital expenditure

67.1 thousand USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Capital expenditure: 279156 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 279156 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 0 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 30557 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 0 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 67064 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 30557 USD · 2014-01-01 – 2014-06-30 Source

Free cash flow

-3.52 million USD

2013-10-01 – 2014-09-30

Exact inputs and evidence

Operating cash flow: -1159641 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -440126 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -1522669 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -2171039 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -1522669 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -2731462 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -2171039 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 279156 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 279156 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 0 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 30557 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 0 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 67064 USD · 2014-01-01 – 2014-09-30 Source
Capital expenditure: 30557 USD · 2014-01-01 – 2014-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-01-11.

Financial data available through: 2013-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2013-12-31
Operating income: 11 of 11 periods available· newest 2013-12-31
Net income: 11 of 11 periods available· newest 2013-12-31
Operating cash flow: 9 of 11 periods available· newest 2013-12-31
Capital expenditure: 3 of 11 periods available· newest 2013-12-31
Total assets: 6 of 11 periods available· newest 2013-12-31
Total liabilities: 4 of 11 periods available· newest 2013-12-31
Current assets: 6 of 11 periods available· newest 2013-12-31
Current liabilities: 6 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-100%

Prior period

USD 20,942

2012-01-01 – 2012-12-31
Current period

USD 0

2013-01-01 – 2013-12-31

Exact inputs and evidence

0 − 20942 = -20942 USD

20942 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
0 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Year-over-year change in Revenue: -20942 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#135622 Filing: 000101376214001204 Input fundies:Revenue: 20942 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#135762 Filing: 000101376214001204
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 11.72 million

Prior period

−USD 4.15 million

2012-01-01 – 2012-12-31
Current period

−USD 15.87 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-15868039 − -4151891 = -11716148 USD

-4151891 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-15868039 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Year-over-year change in Net income: -11716148 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -15868039 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#181883 Filing: 000101376214001204 Input fundies:NetIncome: -4151891 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#182028 Filing: 000101376214001204
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 95,085

Prior period

−USD 1.06 million

2012-01-01 – 2012-12-31
Current period

−USD 1.16 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-1159641 − -1064556 = -95085 USD

-1064556 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-1159641 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Year-over-year change in Operating cash flow: -95085 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1159641 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152707 Filing: 000101376214001204 Input fundies:OperatingCashFlow: -1064556 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152908 Filing: 000101376214001204
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-88.7%

Prior period

USD 2.46 million

2012-01-01 – 2012-12-31
Current period

USD 279,156

2013-01-01 – 2013-12-31

Exact inputs and evidence

279156 − 2461638 = -2182482 USD

2461638 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
279156 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Year-over-year change in Capital expenditure: -2182482 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 279156 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153093 Filing: 000101376214001204 Input fundies:CapitalExpenditure: 2461638 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153292 Filing: 000101376214001204
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 0
Cost of revenue USD 0
Operating expenses USD 5.52 million
Other operating costs Derived USD 0
Operating income −USD 5.52 million
Tax, interest and other Derived USD 10.35 million
Net income −USD 15.87 million

Cash

Operating cash flow −USD 1.16 million
Capital expenditure USD 279,156
Free cash flow Derived −USD 1.44 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Not shown: operating income or net income is not reported.
2005 Operating loss: operating costs were 729% of revenue.
2006 Operating loss: operating costs were 576% of revenue.
2011 Operating loss: operating costs were 18,279% of revenue.
2012 Operating loss: operating costs were 70,301% of revenue.
2013 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	0	3106942 Derived	-3106942	922220 Derived	-4029162	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -3106942 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -4029162 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1066583 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	338215	2464346 Derived	-2126131	-112618 Derived	-2013513	Unavailable	Source 2005-01-01 – 2005-12-31: 338215 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -2126131 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -2013513 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -160025 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	478139	2755280 Derived	-2277141	949603 Derived	-3226744	Unavailable	Source 2006-01-01 – 2006-12-31: 478139 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -2277141 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -3226744 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -289431 USD Inspect Operating Cash Flow Open source
2011 2011-01-01 – 2011-12-31	99192	18131182 Derived	-18031990	14806765 Derived	-32838755	-1581685 Derived	Source 2011-01-01 – 2011-12-31: 99192 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -18031990 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -32838755 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -1039625 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 542060 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	20942	14722532 Derived	-14701590	-10549699 Derived	-4151891	-3526194 Derived	Source 2012-01-01 – 2012-12-31: 20942 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -14701590 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -4151891 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -1064556 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 2461638 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	0	5520735 Derived	-5520735	10347304 Derived	-15868039	-1438797 Derived	Source 2013-01-01 – 2013-12-31: 0 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -5520735 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -15868039 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -1159641 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 279156 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	338215	Revenue: 338215 Open source
20062006-12-31	Revenue	478139	Revenue: 478139 Open source
20112011-12-31	Revenue	99192	Revenue: 99192 Open source
20122012-12-31	Revenue	20942	Revenue: 20942 Open source
20132013-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 338215 Open source Revenue: 0 Open source
20062006-12-31	Year over year	41.4%	Revenue: 478139 Open source Revenue: 338215 Open source
20112011-12-31	Year over year	No prior comparable period	Revenue: 99192 Open source
20122012-12-31	Year over year	-78.9%	Revenue: 20942 Open source Revenue: 99192 Open source
20132013-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 20942 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -70,201.5% 2012

Net margin -19,825.7% 2012

Free cash flow margin -16,837.9% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	Not reported	Operating Income: -3106942 Open source Revenue: 0 Open source
20052005-12-31	Operating margin	-628.6%	Operating Income: -2126131 Open source Revenue: 338215 Open source
20062006-12-31	Operating margin	-476.3%	Operating Income: -2277141 Open source Revenue: 478139 Open source
20112011-12-31	Operating margin	-18,178.9%	Operating Income: -18031990 Open source Revenue: 99192 Open source
20122012-12-31	Operating margin	-70,201.5%	Operating Income: -14701590 Open source Revenue: 20942 Open source
20132013-12-31	Operating margin	Not reported	Operating Income: -5520735 Open source Revenue: 0 Open source
20042004-12-31	Net margin	Not reported	Net Income: -4029162 Open source Revenue: 0 Open source
20052005-12-31	Net margin	-595.3%	Net Income: -2013513 Open source Revenue: 338215 Open source
20062006-12-31	Net margin	-674.9%	Net Income: -3226744 Open source Revenue: 478139 Open source
20112011-12-31	Net margin	-33,106.3%	Net Income: -32838755 Open source Revenue: 99192 Open source
20122012-12-31	Net margin	-19,825.7%	Net Income: -4151891 Open source Revenue: 20942 Open source
20132013-12-31	Net margin	Not reported	Net Income: -15868039 Open source Revenue: 0 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1066583 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 338215 Open source Operating Cash Flow: -160025 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 478139 Open source Operating Cash Flow: -289431 Open source
20112011-12-31	Free cash flow margin	-1,594.6%	Revenue: 99192 Open source Operating Cash Flow: -1039625 Open source Capital Expenditure: 542060 Open source
20122012-12-31	Free cash flow margin	-16,837.9%	Revenue: 20942 Open source Operating Cash Flow: -1064556 Open source Capital Expenditure: 2461638 Open source
20132013-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1159641 Open source Capital Expenditure: 279156 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.2M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-1066583	Operating Cash Flow: -1066583 Open source
20052005-12-31	Operating cash flow	-160025	Operating Cash Flow: -160025 Open source
20062006-12-31	Operating cash flow	-289431	Operating Cash Flow: -289431 Open source
20112011-12-31	Operating cash flow	-1039625	Operating Cash Flow: -1039625 Open source
20122012-12-31	Operating cash flow	-1064556	Operating Cash Flow: -1064556 Open source
20132013-12-31	Operating cash flow	-1159641	Operating Cash Flow: -1159641 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.4M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1066583 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: -160025 Open source
20062006-12-31	Free cash flow	Unavailable	Operating Cash Flow: -289431 Open source
20112011-12-31	Free cash flow	-1581685	Operating Cash Flow: -1039625 Open source Capital Expenditure: 542060 Open source
20122012-12-31	Free cash flow	-3526194	Operating Cash Flow: -1064556 Open source Capital Expenditure: 2461638 Open source
20132013-12-31	Free cash flow	-1438797	Operating Cash Flow: -1159641 Open source Capital Expenditure: 279156 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

482.2% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	Total Assets: 4789 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 111386 Open source
20062006-12-31	Liabilities / assets	364.9%	Total Liabilities: 488257 Open source Total Assets: 133792 Open source
20112011-12-31	Liabilities / assets	1,351.9%	Total Liabilities: 19156807 Open source Total Assets: 1417028 Open source
20122012-12-31	Liabilities / assets	216.5%	Total Liabilities: 7684913 Open source Total Assets: 3549954 Open source
20132013-12-31	Liabilities / assets	482.2%	Total Liabilities: 15495015 Open source Total Assets: 3213664 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	0.01×	Current Assets: 4789 Open source Current Liabilities: 449004 Open source
20052005-12-31	Current assets / current liabilities	0.2×	Current Assets: 101623 Open source Current Liabilities: 497544 Open source
20062006-12-31	Current assets / current liabilities	0.26×	Current Assets: 41773 Open source Current Liabilities: 161398 Open source
20112011-12-31	Current assets / current liabilities	0.03×	Current Assets: 110194 Open source Current Liabilities: 4365516 Open source
20122012-12-31	Current assets / current liabilities	0×	Current Assets: 10159 Open source Current Liabilities: 6697893 Open source
20132013-12-31	Current assets / current liabilities	0×	Current Assets: 9000 Open source Current Liabilities: 15495015 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 4.03 million Exact value Exact value: -4029162 USD 2004-01-01 – 2004-12-31: -4029162 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2004-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -4029162 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4029162 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0000949353-06-000370.txt#1879 The citation records this snapshot. The page link may show a newer release later.	−USD 1.07 million Exact value Exact value: -1066583 USD 2004-01-01 – 2004-12-31: -1066583 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2004-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -1066583 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1066583 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0000949353-06-000370.txt#1894 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 2.01 million Exact value Exact value: -2013513 USD 2005-01-01 – 2005-12-31: -2013513 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2005-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -2013513 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2013513 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0000949353-07-000283.txt#1916 The citation records this snapshot. The page link may show a newer release later.	−USD 160,025 Exact value Exact value: -160025 USD 2005-01-01 – 2005-12-31: -160025 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2005-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -160025 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -160025 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0000949353-07-000283.txt#1928 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 3.23 million Exact value Exact value: -3226744 USD 2006-01-01 – 2006-12-31: -3226744 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2006-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -3226744 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3226744 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-10-004432.txt#5090 The citation records this snapshot. The page link may show a newer release later.	−USD 289,431 Exact value Exact value: -289431 USD 2006-01-01 – 2006-12-31: -289431 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2006-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -289431 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -289431 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0000949353-07-000283.txt#1928 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 1.92 million Exact value Exact value: -1918085 USD 2007-01-01 – 2007-12-31: -1918085 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2007-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -1918085 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1918085 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-000988.txt#5190 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 1.02 million Exact value Exact value: -1024703 USD 2008-01-01 – 2008-12-31: -1024703 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2008-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -1024703 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1024703 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-001454.txt#5070 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 770,205 Exact value Exact value: -770205 USD 2009-01-01 – 2009-12-31: -770205 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2009-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -770205 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -770205 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-003772.txt#5430 The citation records this snapshot. The page link may show a newer release later.	−USD 169,574 Exact value Exact value: -169574 USD 2009-01-01 – 2009-12-31: -169574 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2009-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -169574 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -169574 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-003772.txt#5550 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 3.85 million Exact value Exact value: -3854777 USD 2010-01-01 – 2010-12-31: -3854777 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2010-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -3854777 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3854777 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-003772.txt#5430 The citation records this snapshot. The page link may show a newer release later.	−USD 901,056 Exact value Exact value: -901056 USD 2010-01-01 – 2010-12-31: -901056 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2010-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -901056 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -901056 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/0001437749-11-003772.txt#5550 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 32.84 million Exact value Exact value: -32838755 USD 2011-01-01 – 2011-12-31: -32838755 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2011-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -32838755 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32838755 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376213001225/svfc-20121231.xml#597031 Filing: 000101376213001225 The citation records this snapshot. The page link may show a newer release later.	−USD 1.04 million Exact value Exact value: -1039625 USD 2011-01-01 – 2011-12-31: -1039625 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2011-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -1039625 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1039625 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376213001225/svfc-20121231.xml#606080 Filing: 000101376213001225 The citation records this snapshot. The page link may show a newer release later.	USD 542,060 Exact value Exact value: 542060 USD 2011-01-01 – 2011-12-31: 542060 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Intellicell Biosciences, Inc. · 2011-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Capital Expenditure: 542060 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 542060 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376213001225/svfc-20121231.xml#608249 Filing: 000101376213001225 The citation records this snapshot. The page link may show a newer release later.	−USD 1.58 million Calculation and evidence -1039625 − 542060 USD Exact free cash flow: -1581685 USD 2011-01-01 – 2011-12-31: -1039625 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 542060 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Intellicell Biosciences, Inc. · 2011-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Free cash flow: -1581685 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1039625 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376213001225/svfc-20121231.xml#606080 Filing: 000101376213001225 Input fundies:CapitalExpenditure: 542060 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376213001225/svfc-20121231.xml#608249 Filing: 000101376213001225 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 4.15 million Exact value Exact value: -4151891 USD 2012-01-01 – 2012-12-31: -4151891 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2012-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -4151891 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4151891 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#182028 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	−USD 1.06 million Exact value Exact value: -1064556 USD 2012-01-01 – 2012-12-31: -1064556 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2012-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -1064556 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1064556 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152908 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	USD 2.46 million Exact value Exact value: 2461638 USD 2012-01-01 – 2012-12-31: 2461638 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Intellicell Biosciences, Inc. · 2012-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Capital Expenditure: 2461638 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2461638 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153292 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	−USD 3.53 million Calculation and evidence -1064556 − 2461638 USD Exact free cash flow: -3526194 USD 2012-01-01 – 2012-12-31: -1064556 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 2461638 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Intellicell Biosciences, Inc. · 2012-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Free cash flow: -3526194 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1064556 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152908 Filing: 000101376214001204 Input fundies:CapitalExpenditure: 2461638 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153292 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 15.87 million Exact value Exact value: -15868039 USD 2013-01-01 – 2013-12-31: -15868039 USD Inspect Net Income Open source Share or cite Citation for Net Income · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Net Income: -15868039 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15868039 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#181883 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	−USD 1.16 million Exact value Exact value: -1159641 USD 2013-01-01 – 2013-12-31: -1159641 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Operating Cash Flow: -1159641 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1159641 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152707 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	USD 279,156 Exact value Exact value: 279156 USD 2013-01-01 – 2013-12-31: 279156 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Capital Expenditure: 279156 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 279156 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153093 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.	−USD 1.44 million Calculation and evidence -1159641 − 279156 USD Exact free cash flow: -1438797 USD 2013-01-01 – 2013-12-31: -1159641 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 279156 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Intellicell Biosciences, Inc. · 2013-12-31 Intellicell Biosciences, Inc. (edgar:1125280) Free cash flow: -1438797 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:00:40Z Snapshot: d3571f4524df1cd7e461d9afe846975e6d696a6480f33c0e7aa5556fa861d83f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1125280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1159641 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#152707 Filing: 000101376214001204 Input fundies:CapitalExpenditure: 279156 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1125280/000101376214001204/svfc-20131231.xml#153093 Filing: 000101376214001204 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

82 filings · 1,052 latest values · 1,052 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001125280, 1125280, edgar:1125280

Also known as CHINA WIRELESS COMMUNICATIONS INC, I TRACK INC, Intellicell Biosciences, Inc., Media Exchange Group, Inc.

Intellicell Biosciences, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation